Frontiers in Cardiovascular Drug Discovery: Volume 3

Volume in the series

Frontiers in Cardiovascular Drug Discovery

Publisher:Bentham Science

By: Atta-ur Rahman and M. Iqbal Choudhary

Paid access

|Jan 2016

E-Book €94.99Institutions €383.95

Frontiers in Cardiovascular Drug Discovery is an eBook series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry in-silico drug design combinatorial chemistry high-throughput screening drug targets recent important patents and structure-activity relationships of molecules used in cardiovascular therapy. The eBook series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology.
The third volume of the series covers the following topics:
- P2Y12 receptor agonists
-Heart failure pharmacotherapy
-Vasopressin and the cardiovascular system
-Cerebral small vessel disease
-Complement blocking therapeutic strategies
-New antiplatelet and anticoagulating agents for gastrointestinal treatments

PDF ISBN: 978-1-68108-163-2

Publisher: Bentham Science

Publication date: 2016

Language: English

Pages: 388

Related subjects:

Medicine,

Clinical medicine,

Pharmacology, toxicology

Frontiers in Cardiovascular Drug Discovery: Volume 3

People also read

Publications carousel

Frontiers in Cardiovascular Drug Discovery: Volume 2

Frontiers in Cardiovascular Drug Discovery: Volume 4

Frontiers in Cardiovascular Drug Discovery: Volume 1

Frontiers in Cardiovascular Drug Discovery: Volume 5

Frontiers in Cardiovascular Drug Discovery: Volume 6

Advancements in Cardiovascular Research and Therapeutics: Molecular and Nutraceutical Perspectives

Frontiers in Medicinal Chemistry: Volume 9

Frontiers in Drug Design and Discovery: Volume 2

Frontiers in Drug Design and Discovery: Volume 3

Frontiers in Drug Design and Discovery: Volume 4

Paradigm

My account